TL;DR: BR 384 (CAS 123567-35-1) is a chemical compound with molecular formula C16H18BrClN2O6 and molecular weight 448.0037 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
4-[2-bromoethyl(methyl)amino]but-2-ynyl N-(3-chlorophenyl)carbamate;oxalic acid
Also Known As: BR 384, 4-((2-Bromoethyl)methylamino)-2-butynyl N-(3-chlorophenyl)carbamate oxalate, Carbamic acid, (3-chlorophenyl)-, 4-((2-bromoethyl)methylamino)-2-butynyl ester, ethanedioate (1:1), 4-((2-Bromoethyl)methylamino)-2-butynyl (3-chlorophenyl)carbamate ethanedioate (1:1), 4-[2-bromoethyl(methyl)amino]but-2-ynyl N-(3-chlorophenyl)carbamate;oxalic acid
| Molecular Formula | C16H18BrClN2O6 |
| Molecular Weight | 448.0037 g/mol |
| XLogP | 2.3742 |
| Topological Polar Surface Area (TPSA) | 116.0 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Exact Mass | 448.0037 Da |
| Heavy Atoms | 26 |
| Complexity | 438.0 |
| SMILES | CN(CCBr)CC#CCOC(=O)NC1=CC(=CC=C1)Cl.C(=O)(C(=O)O)O |
| InChIKey | RLNCYWGKUIFYRC-UHFFFAOYSA-N |
The XLogP value of 2.3742 suggests moderate lipophilicity, balancing water solubility and membrane permeability for BR 384. The TPSA of 116.0 Ų falls within the moderate polarity range, balancing permeability and solubility for BR 384. Following Lipinski's Rule of Five, BR 384 has 3 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of BR 384 is 123567-35-1.
The molecular formula of BR 384 is C16H18BrClN2O6.
The molecular weight of BR 384 is 448.0037 g/mol.
You can request a quote for BR 384 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for BR 384 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 123567-35-1. Our professional technical team will respond with pricing and lead time.